Included under terms of UK Non-commercial Government License.
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Julious SA, Horspool MJ, Davis S, et al. PLEASANT: Preventing and Lessening Exacerbations of Asthma in School-age children Associated with a New Term – a cluster randomised controlled trial and economic evaluation. Southampton (UK): NIHR Journals Library; 2016 Dec. (Health Technology Assessment, No. 20.93.)
PLEASANT: Preventing and Lessening Exacerbations of Asthma in School-age children Associated with a New Term – a cluster randomised controlled trial and economic evaluation.
Show detailsTABLE 39
Study | Reasons for exclusion |
---|---|
Janse A, Sinnema G, Uiterwaal C, Kimpen J, Gemke R. Quality of life in chronic illness: perceptions of parents and paediatricians. Arch Dis Child 2005;90:486–91 | Used HUI-3, but did not report utility data. Results were presented as percentage similarity in outcome measurements between physician and parents |
Mo F, Choi BC, Li FC, Merrick J. Using Health Utility Index (HUI) for measuring the impact on health-related quality of Life (HRQL) among individuals with chronic diseases. Sci World J 2004;4:746–57 | Used HUI-3, but did not report utility data. Results were presented as graphical differences of quality of life between diseases |
Willems DC, Joore MA, Nieman FH, Severens JL, Wouters EF, Hendriks JJ. Using EQ-5D in children with asthma, rheumatic disorders, diabetes, and speech/language and/or hearing disorders. Int J Technol Assess Health Care 2009;25:391–9 | Used EQ-5D, but did not report utility data. Results were presented as EQ-5D interclass coefficients and Spearman coefficients between outcome measures |
Burstrom K, Svartengren M, Egmar AC. Testing a Swedish child-friendly pilot version of the EQ-5D instrument – initial results. Eur J Public Health 2011;21:178–83 | Used direct valuation using EQ-VAS as outcome measure (non-preference based) in Swedish children |
Finnell SM, Carroll AE, Downs SM. Application of classic utilities to published pediatric cost-utility studies. Acad Pediatr 2012;12:219–28 | Utility data were obtained from an included study by Carroll and Downs55 |
Brodtkorb TH, Zetterstrom O, Tinghog G. Cost-effectiveness of clean air administered to the breathing zone in allergic asthma. Clin Respir J 2010;4:104–10 | Utility data were presented as utility changes associated with intervention |
Meadows A, Kaambwa B, Novielli N, Huissoon A, Fry-Smith A, Meads C, et al. A systematic review and economic evaluation of subcutaneous and sublingual allergen immunotherapy in adults and children with seasonal allergic rhinitis. Health Technol Assess 2013;17(27) | |
Smith LJ, Holbrook JT, Wise R, Blumenthal M, Dozor AJ, Mastronarde J, et al. Dietary intake of soy genistein is associated with lung function in patients with asthma. J Asthma 2004;41:833–43 | |
Wilson EC, Price D, Musgrave SD, Sims EJ, Shepstone L, Murdoch J, et al. Cost effectiveness of leukotriene receptor antagonists versus long-acting beta-2 agonists as add-on therapy to inhaled corticosteroids for asthma: a pragmatic trial. PharmacoEconomics 2010;28:597–608 | |
Wilson EC, Sims EJ, Musgrave SD, Shepstone L, Blyth A, Murdoch J, et al. Cost effectiveness of leukotriene receptor antagonists versus inhaled corticosteroids for initial asthma controller therapy: a pragmatic trial. PharmacoEconomics 2010;28:585–95 |
- Reasons for exclusion at full texts - PLEASANT: Preventing and Lessening Exacerb...Reasons for exclusion at full texts - PLEASANT: Preventing and Lessening Exacerbations of Asthma in School-age children Associated with a New Term – a cluster randomised controlled trial and economic evaluation
Your browsing activity is empty.
Activity recording is turned off.
See more...